Related Experiment Video
Updated: Aug 11, 2026
10:07
High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
QSAR studies on benzopyran potassium channel activators
Vijay K Agrawal1, Jyoti Singh, Madhu Gupta
1QSAR and Computer Chemical Laboratories, APS University, Rewa, India.
European Journal of Medicinal Chemistry
|February 7, 2006
Summary
Quantitative Structure-Activity Relationship (QSAR) studies explored benzopyrans as potassium channel activators. Models incorporating topological indices and molecular descriptors accurately predicted relaxant potency in rat trachea.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
- Pharmacology
Background:
- Benzopyrans are investigated for their potential as potassium channel activators.
- Understanding the structure-activity relationships of benzopyrans is crucial for drug development.
Purpose of the Study:
- To perform Quantitative Structure-Activity Relationship (QSAR) studies on benzopyrans as potassium channel activators.
- To establish a predictive model for the relaxant potency of benzopyrans.
Main Methods:
- Utilized a series of benzopyrans with varying structures.
- Employed distance-based topological indices, negentropy, and molecular redundancy indices as molecular descriptors.
- Assessed biological activity using relaxant potency in rat trachea (pEC(50)).
- Developed multiparametric models, including an indicator parameter, to correlate structure with activity.
Main Results:
- QSAR models demonstrated excellent predictive power for the relaxant potency (pEC(50)) of benzopyrans.
- The inclusion of an indicator parameter significantly improved model performance.
- Cross-validation parameters were used to assess the predictive capabilities of the developed models.
Conclusions:
- QSAR analysis provides a valuable tool for understanding the mechanism of potassium channel activation by benzopyrans.
- The developed models can guide the design of novel benzopyran derivatives with enhanced therapeutic potential.
- Further validation and experimental studies are warranted to confirm these findings.
Related Concept Videos
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:24Non-gated Ion Channels
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
01:26Voltage-gated Ion Channels
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...